Modern Diagnostic IPO is a book-built issue, the total issue size of which has been kept at ₹36.89 crore. This IPO is a completely fresh issue, in which about 0.41 crore new shares will be offered. The entire amount raised from this issue will be used for the growth plans and operational needs of the company. Bidding of Modern Diagnostic IPO will open on 31 December 2025 and will close on 2 January 2026. The allotment of IPO is likely to be finalized on 5 January 2026. This IPO will be listed on the BSE SME platform, whose tentative listing date has been fixed as 7 January 2026. The price band of the IPO is ₹85–₹90 per share. Lot size is 1,600 shares. The minimum investment for retail investors will be around ₹2.88 lakh.

Dhara Rail Projects IPO is a book build issue of ₹50.20 crore. The issue is a completely fresh issue of 0.40 crore shares, worth ₹50.20 crore.

Dhara Rail Projects IPO will open for subscription on December 23, 2025 and close on December 26, 2025.

The allotment of Dhara Rail Projects IPO is expected to be final on December 29, 2025. Dhara Rail Projects IPO will be listed on NSE SME, the probable listing date of which has been fixed as December 31, 2025.

Nephrocare Health IPO is much discussed among investors. This is a Book Build Issue of ₹871.05 crore which includes Fresh Issue of ₹353.40 crore and Offer For Sale (OFS) of ₹517.64 crore. Bidding for IPO started on 10 December 2025 and will close on 12 December 2025. Allotment is expected on 15 December 2025 and this share will be listed on BSE and NSE on 17 December 2025. The price band of this IPO has been fixed at ₹438 to ₹460 per share. For Retail Investors, one lot will contain 32 shares, for which the minimum investment amount will be ₹ 14,720 (at the upper price brand). Whereas for SMNI, a bid of 14 Lot (₹ 2,06,080) will have to be made and for bNII, 68 Lot (₹ 10,00,960) will have to be bid. There is also a special reservation for employees in this issue—83,532 shares, which will be given at a discount of ₹41. The Book Running Lead Manager of this IPO is ICICI Securities and Kfin Technologies is playing the role of Registrar. Nephrocare Health is a leading company providing Kidney Care and Diagnostic Services in India. Be sure to consult your financial advisor before investing in IPO. For more information see Nephrocare Health IPO RHP.

Corona Remedies IPO is a book build issue of ₹655.37 crore. The issue is an offer for sale of 0.62 crore shares worth ₹655.37 crore. Bidding for Corona Remedies IPO will open for subscription on December 8, 2025 and will close on December 10, 2025. The allotment of Corona Remedies IPO is expected to be finalized on December 11, 2025. Corona Remedies IPO will be listed on BSE, NSE, with the probable listing date fixed at December 15, 2025. The price band of Corona Remedies IPO has been fixed at ₹1008.00 to ₹1062.00 per share. The lot size for one application is 14. The minimum investment amount required for a retail investor is ₹14,868 (14 shares) (based on cap price). The lot size investment for sNII is 14 lots (196 shares), amounting to ₹2,08,152, and for bNII it is 68 lots (952 shares), amounting to ₹10,11,024. The issue includes reservation of 58,036 shares for employees, which are being offered at a discount of ₹54.00 to the issue price.

Methodhub Software IPO is a book build issue of ₹103.02 crore. The issue is a combination of fresh issue of 0.45 crore shares, aggregate value of ₹87.50 crore and offer for sale of 0.08 crore shares, aggregate value of ₹15.52 crore. Bidding for Methodhub Software IPO will open for subscription on December 5, 2025 and close on December 9, 2025. The allotment of Methodhub Software IPO is expected to be finalized on December 10, 2025. Methodhub Software IPO will be listed on BSE SME, with a tentative listing date of December 12, 2025. The price band of Methodhub Software IPO has been fixed at ₹190.00 to ₹194.00 per share. The lot size for one application is 600.

Wakefit Innovations IPO is a book build issue worth ₹1,288.89 crore. The issue is a combination of fresh issue of 1.93 crore shares, aggregating to ₹377.18 crore and offer for sale of 4.68 crore shares, aggregating to ₹911.71 crore. Wakefit Innovations IPO will open for subscription on December 8, 2025 and close on December 10, 2025. The allotment of Wakefit Innovations IPO is expected to be finalized on December 11, 2025. Wakefit Innovations IPO will be listed on BSE and NSE, the probable listing date of which has been fixed as December 15, 2025. The price band of Wakefit Innovations IPO has been fixed at ₹185.00 to ₹195.00 per share. The lot size for an application is 76.

Flywings Simulator Training IPO is a book build issue worth ₹57.05 crore. The issue is a fresh issue of 0.25 crore new shares, having an aggregate value of ₹47.99 crore, and an offer for sale of 0.05 crore shares, having an aggregate value of ₹9.05 crore. Bidding for Flywings Simulator Training IPO will open for subscription on December 5, 2025 and will close on December 9, 2025. The allotment of Flywings Simulator Training IPO is expected to be finalized on December 10, 2025. Flywings Simulator Training IPO will be listed on NSE SME, with a tentative listing date of December 12, 2025. The price band of Flywings Simulator Training IPO has been fixed at ₹181.00 to ₹191.00 per share.

Aequs IPO is a book build issue of ₹921.81 crore. The issue is a combination of fresh issue of 5.40 crore shares, giving a total of ₹670.00 crore and offer for sale of 2.03 crore shares, giving a total of ₹251.81 crore. Bidding for Aequs IPO will open for subscription on December 3, 2025 and close on December 5, 2025. The allotment for Aequs IPO is expected to be final on December 8, 2025. Aequs IPO will be listed on BSE, NSE and the probable date of listing has been fixed as December 10, 2025. The price band of Aequs IPO has been fixed at ₹118.00 to ₹124.00 per share.

In this video we will do complete analysis of Vidya Wires IPO 2025. The total size of Vidya Wires IPO is ₹300.01 crore which includes Fresh Issue of 5.27 crore shares and Offer For Sale of 0.50 crore shares. The IPO will be open for investment from December 3, 2025 to December 5, 2025. The price band is ₹48 to ₹52 per share and one lot will contain 288 shares. Minimum Investment for Retail Investors is ₹14,976 and for HNI/NII is ₹10,03,392. Book Running Lead Manager Pantomath Capital Advisors Pvt. Ltd. and Registrar MUFG Intime India Pvt. Ltd. Is. Face value is ₹1 per share. In the share allotment, 50% shares have been reserved for QIBs, 35% for Retail Investors and 15% for NII. Vidya Wires was established in 1981 and the company manufactures Copper and Aluminum wires. Its major products include precision-engineered wires, copper strips, conductors, busbars, specialized winding wires, PV ribbons and aluminum paper-covered strips. Revenue of Vidya Wires was ₹ 1,015.72 crore on 31 March 2023, which increased to ₹ 1,188.49 crore on 31 March 2024 and ₹ 1,491.45 crore on 31 March 2025. Profit After Tax was ₹21.53 crore on 31 March 2023, which increased to ₹25.68 crore on 31 March 2024 and ₹40.87 crore on 31 March 2025. Revenue increased by 25% and PAT increased by 59%. Gray Market Premium is ₹6 and Listing Date is 10th December 2025.